193 related articles for article (PubMed ID: 7479939)
21. Multi-log cytotoxicity of carbocyclic 2'-deoxyguanosine in HSV-TK-expressing human tumor cells.
Shewach DS; Murphy PJ; Robinson BW; Vuletich J; Boucher PD; Blobaum AL; Zerbe L; Secrist JA; Parker WB
Hum Gene Ther; 2002 Mar; 13(4):543-51. PubMed ID: 11874632
[TBL] [Abstract][Full Text] [Related]
22. Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovir.
Gentry BG; Boucher PD; Shewach DS
Cancer Res; 2006 Apr; 66(7):3845-51. PubMed ID: 16585212
[TBL] [Abstract][Full Text] [Related]
23. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
24. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
25. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B
Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of ATP-sensitive potassium channels increases HSV-tk/GCV bystander effect in U373 human glioma cells by enhancing gap junctional intercellular communication.
Paíno T; Gangoso E; Medina JM; Tabernero A
Neuropharmacology; 2010 Nov; 59(6):480-91. PubMed ID: 20603136
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication.
Xiao J; Zhang G; Qiu P; Liu X; Wu Y; Du B; Li J; Zhou J; Li J; Tan Y
PLoS One; 2013; 8(7):e67662. PubMed ID: 23861780
[TBL] [Abstract][Full Text] [Related]
28. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
29. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
Zhang L; Liu T; Cui Q; Gao J
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559
[TBL] [Abstract][Full Text] [Related]
30. cAMP stimulates the bystander effect in suicide gene therapy of human choriocarcinoma.
Kunishige I; Samejima Y; Moriyama A; Saji F; Murata Y
Anticancer Res; 1998; 18(5A):3411-9. PubMed ID: 9858917
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
Robe PA; Nguyen-Khac M; Jolois O; Rogister B; Merville MP; Bours V
BMC Cancer; 2005 Apr; 5():32. PubMed ID: 15804364
[TBL] [Abstract][Full Text] [Related]
32. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells.
Freeman SM; Ramesh R; Shastri M; Munshi A; Jensen AK; Marrogi AJ
Cancer Lett; 1995 Jun; 92(2):167-74. PubMed ID: 7600527
[TBL] [Abstract][Full Text] [Related]
33. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation.
McMasters RA; Saylors RL; Jones KE; Hendrix ME; Moyer MP; Drake RR
Hum Gene Ther; 1998 Oct; 9(15):2253-61. PubMed ID: 9794209
[TBL] [Abstract][Full Text] [Related]
34. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models.
Garcia-Rodríguez L; Abate-Daga D; Rojas A; González JR; Fillat C
Gene Ther; 2011 Jan; 18(1):73-81. PubMed ID: 20720574
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro.
Tanaka T; Yamasaki H; Mesnil M
Int J Cancer; 2001 Feb; 91(4):538-42. PubMed ID: 11251978
[TBL] [Abstract][Full Text] [Related]
37. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
Robe PA; Princen F; Martin D; Malgrange B; Stevenaert A; Moonen G; Gielen J; Merville M; Bours V
Biochem Pharmacol; 2000 Jul; 60(2):241-9. PubMed ID: 10825469
[TBL] [Abstract][Full Text] [Related]
39. Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene.
Cho HS; Lee HR; Kim MK
J Korean Med Sci; 2004 Feb; 19(1):107-12. PubMed ID: 14966351
[TBL] [Abstract][Full Text] [Related]
40. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
Freeman SM; Abboud CN; Whartenby KA; Packman CH; Koeplin DS; Moolten FL; Abraham GN
Cancer Res; 1993 Nov; 53(21):5274-83. PubMed ID: 8221662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
